Research on the role of gut microbiota metabolites in autism by multi-omics and network pharmacology.
Overview
- Department of Pediatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
- The First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
- College of Computer Science, Guangdong Polytechnic Normal University, Guangzhou, Guangdong, China
- Department of Microbiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China
- Department of Emergency, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
Abstract
Objective: The relationship and underlying mechanisms linking the gut microbiota, metabolites and autism spectrum disorder (ASD) have not been fully elucidated.
Methods: In the present study, network pharmacology was combined with machine learning for a systematic investigation into the possible action mechanisms between metabolites derived from the gut microbiota and their targets in ASD. Subsequently, untargeted metabolomics analysis and 16S rRNA sequencing were utilized for investigating alterations in differential metabolites and the composition of principal gut microbiota between normal and BTBR mice.
Results: The findings demonstrated that five characteristic targets: CXCR3, HCAR2, HTR1A, IL-6 and NFKB1 modulated by the gut microbiota and gut microbiota’s metabolites were significantly associated with ASD. The M-S-M-T network prioritized 21 candidate gut-microbiota-derived metabolites, including phenylacetic acid and coumarin. These candidates were generated from database-based target prediction and should be interpreted separately from the differential metabolites detected in fecal metabolomics. Metabolomic and 16S rRNA sequencing analyses revealed that BTBR mice displayed metabolic dysregulation and disrupted gut microbiota composition compared with normal ones. These findings suggest that phenylalanine metabolism and neuroactive ligand-receptor interaction may be associated with ASD-like behavioral phenotypes in BTBR mice and warrant further experimental validation. The gut microbiota-metabolite-be
Conclusion: By integrating network pharmacology, transcriptomic re-analysis, fecal metabolomics and 16S rRNA sequencing, this study identifies candidate microbe-metabolite-targe
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- bioproject:PRJNA1496513, at NCBI BioProject; found in “Data availability statement”
Other data links
- ncbi.nlm.nih.gov/
geo , NCBI; found in the end of the paper
Data availability statement
The original contributions presented in the study are publicly available. The main data generated or analyzed during this study are included in this manuscript and its additional files and are available from the corresponding author on reasonable request. 16s rRNA sequencing data can be found at: https://
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, pages, dates, 9 authors, 5 keywords, 71 references.
Cite
This paper
Hu, X., Zeng, Y., Li, J., Lin, Q., Liang, Z., Zhang, J., Jiang, M., Gao, S., & Liu, H. (2026). Research on the role of gut microbiota metabolites in autism by multi-omics and network pharmacology. Frontiers in microbiology, 17, 1811435. https://
BibTeX
@article{hu2026research,
author = {Hu, Xiaoyun and Zeng, Yuning and Li, Junjie and Lin, Qiongxi and Liang, Zixuan and Zhang, Jing and Jiang, Meirong and Gao, Shuoshuo and Liu, Hua},
title = {{Research on the role of gut microbiota metabolites in autism by multi-omics and network pharmacology}},
journal = {Frontiers in microbiology},
year = {2026},
month = aug,
volume = {17},
pages = {1811435},
publisher = {Frontiers Media SA},
issn = {1664-302X},
doi = {10.3389/
url = {https://
pmid = {42614415},
pmcid = {PMC13481684}
}
RIS
TY - JOUR
AU - Hu, Xiaoyun
AU - Zeng, Yuning
AU - Li, Junjie
AU - Lin, Qiongxi
AU - Liang, Zixuan
AU - Zhang, Jing
AU - Jiang, Meirong
AU - Gao, Shuoshuo
AU - Liu, Hua
TI - Research on the role of gut microbiota metabolites in autism by multi-omics and network pharmacology
T2 - Frontiers in microbiology
J2 - Front Microbiol
PY - 2026
DA - 2026/
VL - 17
SP - 1811435
SN - 1664-302X
PB - Frontiers Media SA
DO - 10.3389/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.3389/
"type": "article-journal",
"title": "Research on the role of gut microbiota metabolites in autism by multi-omics and network pharmacology",
"container-title": "Frontiers in microbiology",
"author": [
{
"family": "Hu",
"given": "Xiaoyun"
},
{
"family": "Zeng",
"given": "Yuning"
},
{
"family": "Li",
"given": "Junjie"
},
{
"family": "Lin",
"given": "Qiongxi"
},
{
"family": "Liang",
"given": "Zixuan"
},
{
"family": "Zhang",
"given": "Jing"
},
{
"family": "Jiang",
"given": "Meirong"
},
{
"family": "Gao",
"given": "Shuoshuo"
},
{
"family": "Liu",
"given": "Hua"
}
],
"container-title-short":
"volume": "17",
"page": "1811435",
"DOI": "10.3389/
"PMID": "42614415",
"PMCID": "PMC13481684",
"ISSN": "1664-302X",
"publisher": "Frontiers Media SA",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
8,
4
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1186/s12888-026-08178-8 [code]
- Machine learning model to identify gut microbiome-derived metabolites as potential biomarkers of autism spectrum disorder: a pilot study.Journal: BMC psychiatryIn common: autism, genetics / omics, 4 references
- [2] doi:10.1038/s41467-025-61544-0 [code]
- Gut microbiota and brain-resident CD4&
lt;sup& gt;+& lt;/ sup& gt; T cells shape behavioral outcomes in autism spectrum disorder. Journal: Nature communicationsIn common: autism, mouse, 4 references - [3] doi:10.3389/fmicb.2024.1331130
- Microbiota profiling reveals alteration of gut microbial neurotransmitters in a mouse model of autism-associated 16p11.2 microduplication.Journal: Frontiers in microbiologyIn common: autism, genetics / omics, mouse, 3 references
- [4] doi:10.3389/fmicb.2026.1885281
- Washed microbiota transplantation improves clinical symptoms, gut microbiota, and metabolic profiles in autism spectrum disorder in a twin cohort.Journal: Frontiers in microbiologyIn common: autism, genetics / omics, 3 references
- [5] doi:10.1038/s41598-025-91344-x
- Exploring the active ingredients and potential mechanisms of Pingchan granules in Parkinson's disease treatment through network pharmacology and transcriptomics.Journal: Scientific reportsIn common: genetics / omics, 5 references
- [6] doi:10.1080/19490976.2024.2385524 [code]
- Supplier-origin gut microbiomes affect host body weight and select autism-related behaviors.Journal: Gut microbesIn common: autism, mouse, 3 references
- [7] doi:10.1128/msystems.00608-22
- Unique Features of the Gut Microbiome Characterized in Animal Models of Angelman Syndrome.Journal: mSystemsIn common: genetics / omics, mouse, 3 references
- [8] doi:10.1021/acsomega.4c00200
- Investigating the Mechanistic of Danhong Injection in Brain Damage Caused by Cardiac I/
R Injury via Bioinformatics, Computer Simulation, and Experimental Validation. Journal: ACS omegaIn common: 4 references - [9] doi:10.3390/cimb48040369
- Elucidating the Multi-Target Anti-Pruritic Mechanism of &
lt;i& gt;Polygonatum odoratum& lt;/ i& gt; via Integrated Network Pharmacology, Molecular Simulations, and GEO Dataset Validation. Journal: Current issues in molecular biologyIn common: 4 references - [10] doi:10.3390/nu15071620
- Intestinal Barrier Dysfunction and Microbiota-Gut-Brain Axis: Possible Implications in the Pathogenesis and Treatment of Autism Spectrum Disorder.Journal: NutrientsIn common: autism, 3 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
